Machine learning cluster analysis identifies increased 12-month mortality risk in transcatheter aortic valve replacement recipients

机器学习聚类分析发现经导管主动脉瓣置换术患者12个月死亡风险增加

阅读:2

Abstract

BACKGROUND: Long-term mortality risk is seldom re-assessed in contemporary clinical practice following successful transcatheter aortic valve implantation (TAVR). Unsupervised machine learning permits pattern discovery within complex multidimensional patient data and may facilitate recognition of groups requiring closer post-TAVR surveillance. METHODS: We analysed and differentiated routinely collected demographic, biochemical, and cardiac imaging data into distinct clusters using unsupervised machine learning. k-means clustering was performed on data from 200 patients who underwent TAVR for severe aortic stenosis (AS). Input features were ranked according to their influence on cluster assignment. Survival analyses were performed with Kaplan-Meier and Cox proportional hazards models. Nested cox models were used to identify any incremental prognostic benefit cluster assignment achieved beyond conventional risk scores. RESULTS: Analysis identified two distinct clusters. Compared to Cluster 1, Cluster 2 demonstrated significantly worse all-cause mortality at 12 months (HR 6.3, p < 0.01), and was characterised by more advanced cardiac remodelling with worse indices of multi-chamber cardiac function, as quantified by strain imaging. Cluster assignment demonstrated greater predictive power for 12-month mortality as compared with conventional risk and frailty calculators. CONCLUSION: k-means clustering identified two prognostically distinct phenogroups of patients who had undergone TAVR with better discriminatory power than conventional risk and frailty calculators. Our results highlight the utility of machine learning applications for clinical risk prediction and scope to improve patient surveillance.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。